Asia Pacific E.Coli Water Testing Kits Market is expected to reach US$ 59,979.07 thousand by 2028

Institutional Segment to Dominate APAC E.Coli Water Testing Kits Market during 2021–2028

According to a new market research study on “APAC E.Coli Water Testing Kits Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Application and Technology” is expected to reach US$ 59,979.07 thousand by 2028 from US$ 36,802.90 thousand in 2021. The market is estimated to grow at a CAGR of 7.2% from 2021 to 2028. The report provides trends prevailing in the APAC E.Coli water testing kits market along with the drivers and restraints pertaining to the market growth. Surging water pollution in developing countries is the major factor driving the growth of the APAC E.Coli water testing kits market. However, issues associated with the cost associated with e-coli water testing hinder the growth of APAC E.Coli water testing kits market.

The APAC E.Coli water testing kits market has been segmented based on analyte, application, and country. On the basis of analyte, the APAC E.Coli water testing kits market is segmented into E. Coli and coliforms. The E. Coli segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on application, the market is segmented into institutional, government research, commercial, beverage and food processing, hospitality, healthcare, and others. The institutional segment dominated the market in 2020 and government research segment is expected to be the fastest growing during the forecast period. Based on country, the APAC E.Coli water testing kits market is classified into Japan, China, India, Australia, South Korea, and Rest of APAC.

The 2019 novel coronavirus (2019-nCoV) was officially named COVID-19 by the WHO that has spread to more than 180 countries, including China; therefore, the disease was named the global pandemic. The spread of the COVID-19 pandemic has emphasized health data sharing and interoperability under the microscope. Pediatric coronavirus disease-19 (COVID-19) infection is comparatively mild compared to adults, and children are assigned a better prognosis. The interruptions in the supply chain and the massive demand for efficient treatments for the therapy of COVID-19 have put the health research industry in the Asia-Pacific region in a crucial position. The COVID-19 pandemic has had a major influence on international trade and commerce. India, too, has suffered owing to unexpected economic disruptions caused by interim restrictions on public activities and regional lockdowns. Asia’s value chains have closely integrated the economies of China, Japan, South Korea, Hong Kong, and other Asian countries. Such dense and extremely coordinated value chains enable exploiting massive economies of scale in manufacturing. China’s manufacturing Purchasing Managers Index (PMI) declined sharply to levels equivalent to those throughout the 2009 international monetary crisis and despite the March rebound, there were many proofs indicating a pointy contraction in growth within the first quarter of 2020. During the COVID-19 pandemic, most programs in this region were affected, but to varying degrees, influenced mainly by the severity of the local pandemic. Medical device manufacturers and suppliers are shifting their focus to developing and supplying COVID-19 essentials and medical devices for respiratory diseases. This scenario harms the market. This pandemic is affecting the operations of the various key players operating in this region. Considering the geographic and economic operations between Asian countries and China, the countries are expected to witness challenge of COVID-19. Domestic start-ups backed by international funding have already started witnessing back out from investors putting the development of the products in jeopardy. In these unprecedented times, biotechnology and pharmaceutical companies are responding to the rapid challenges arising from disruption in supply chains and the need to change business processes. If this pandemic lasts for a longer time, it may impact the supply of active material and ingredients along with the import and export of biotechnology and biopharmaceuticals. There is also the potential for negative impacts of both a medium- and longer-term nature on R&D and manufacturing activities, and delay on projects. These factors are affecting the growth of the E. coli water testing market in the region.

BIO-RAD LABORATORIES INC.; Hach.; IDEXX LABORATORIES, INC.; NEOGEN Corporation; TINTOMETER GMBH; and WILHELMSEN are among the leading companies in the APAC E.Coli water testing kits market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Sedaru Inc., a leading provider of water utility management software, has been acquired by Aquatic Informatics and will join Danaher’s Water Quality platform.

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com